← Back to feed

Medpal AI PLC

MPAL · AIM · Health Care · mcap £63m today

All announcements

All RNS · 65 Key events · 50

06 Oct 26

September Update and Circular to Shareholders

Top line revenue growth takes annualised run rate to over £38 million
RNS 9807662 ↗
21 Sep 26

Issue of Equity and Trading Update
RNS 9780789 ↗
11 Sep 26

Exercise of Warrants

MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-powered, integrated digital health and pharmacy company, announces that the Company has received a notice to exercise warrants over a total of 4,130,833 new ordinary shares of 0.0002 pence each in the Company at...
RNS 9767991 ↗
09 Sep 26

Board Change and Issue of Options

Appointment of Non-executive Director and Issue of Options
RNS 9762959 ↗
07 Sep 26

August Trading Update

From zero to £28 million annualised in ten months
RNS 9757541 ↗
04 Sep 26

Completion of eMARx Acquisition-Issue of Equity

Final Consideration for eMARx, Issue of Equity and Total Voting Rights
RNS 9756694 ↗
01 Sep 26

FDA Approval of Mounjaro for Heart Protection

US Approval of Mounjaro for Heart Protection Dramatically Expands the GLP-1 Market
RNS 9749319 ↗
11 Aug 26

UK Authorises Eli Lilly's Once Daily GLP-1 Pill

UK First in Europe to Authorise Eli Lilly's Once Daily GLP-1 Weight Loss Pill
RNS 9715779 ↗
04 Aug 26

July Trading Update

July Trading Update: Record Month Across All Three Revenue Streams
RNS 9702437 ↗
03 Aug 26

Total Voting Rights
RNS 9702010 ↗
20 Jul 26

Acquisition of eMARx

Acquisition of eMARx: the digital medication layer for the UK care home market
RNS 9675774 ↗
03 Jul 26

Placing to raise £5m

Funding to complete the acquisition of Solid State Technologies Ltd and capture the UK launch of oral Wegovy®
RNS 9650670 ↗
01 Jul 26

Approval of New Dispensing Facility

Opening of Sarus Court - the Group's largest robotic dispensing facility to date
RNS 9645613 ↗
18 Jun 26

Launch of Juno, MedPal's AI Health Companion

Launch of "Juno": MedPal AI's Agentic AI Health Companion
RNS 9624094 ↗
12 Jun 26

Approval of First Oral GLP-1 for Weight Loss in UK

MHRA Approval of First Oral GLP-1 for Weight Loss in the UK
RNS 9614700 ↗
10 Jun 26

Launch of new.co.uk Marketing Campaign

Commercial Update: new.co.uk Marketing Campaign Launch and Positioning Ahead of Anticipated UK Oral GLP-1 Availability
RNS 9610040 ↗
01 Jun 26

Pharmacy Operational Update

Record Monthly Dispensing Volume - Best Month Since Launch
RNS 9593226 ↗
29 May 26

Half-year Results

Interim Results for the six months ended 28 February 2026
RNS 9590889 ↗
20 May 26

Launch of New Health dedicated GLP/peptides brand

Launch of New Health on new.co.uk as dedicated GLP-1 and peptides brand
RNS 9576504 ↗
01 May 26

Change of Registered Office
RNS 9549674 ↗
30 Apr 26

Total Voting Rights-replacement
RNS 9547312 ↗
30 Apr 26

Total Voting Rights
RNS 9547166 ↗
29 Apr 26

Acquisition of Remedi Pharmacy Assets

Pathway to pharmacy EBITDA breakeven at 80,000 items per month
RNS 9542858 ↗
22 Apr 26

Holding(s) in Company
RNS 9533340 ↗
22 Apr 26

Holding(s) in Company
RNS 9533339 ↗
20 Apr 26

Issue of Fee Shares

MedPal AI Plc (AIM: MPAL, FRA: Z1N), the UK digital health and AI company, announces that it has issued 3,600,000 new ordinary shares ("Fee Shares") in lieu of £90,000 of cash in respect of advisory fees incurred by the Company.
RNS 9528983 ↗
17 Apr 26

Placing to raise £3m

MedPal AI Plc (AIM: MPAL, FRA: Z1N), the UK digital health and AI company, is pleased to announce that it has conditionally raised gross proceeds of £3 million (the "Placing") through the issue of 120,000,000 new ordinary shares of £0.0002 each (the...
RNS 9524817 ↗
08 Apr 26

Updated Research Note

MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to announce the release of an updated research note by Optimo Research, alongside a new investor interview with CEO Jason Drummond.
RNS 9510750 ↗
08 Apr 26

Launch of MedPal Health OS

MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to provide an update on its technology platform strategy and the launch of the MedPal Health Operating System ("OS").
RNS 9509101 ↗
07 Apr 26

Pharmacy Operational Update

MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to announce a record month of pharmacy dispensing activity at its wholly owned subsidiary, MedPal Limited.
RNS 9506992 ↗
02 Apr 26

Result of AGM - Replacement
RNS 9505796 ↗
02 Apr 26

Holding(s) in Company
RNS 9505788 ↗
02 Apr 26

Holding(s) in Company
RNS 9505782 ↗
31 Mar 26

Total Voting Rights
RNS 9500476 ↗
30 Mar 26

Result of AGM
RNS 9498322 ↗
25 Mar 26

Result of WRAP Retail Offer

Further to its announcement of 20 March 2026, MedPal AI plc (AIM: MPAL, FRA:Z1N), the UK digital health and AI company, is pleased to confirm the result of its WRAP Retail Offer ("WRAP").
RNS 9491468 ↗
20 Mar 26

WRAP Retail Offer

MedPal AI plc (AIM: MPAL), the digital health platform, is pleased to announce that it is undertaking a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £200,000 (the "WRAP Retail Offer") through the issue of up to 8,000,000...
RNS 9485333 ↗
20 Mar 26

Placing and WRAP Retail Offer

MedPal AI (AIM: MPAL, FRA: Z1N) the UK digital health and AI company, is pleased to announce that it has conditionally raised approximately £527,000 ("Placing") by way of the issue of 21,080,000 new ordinary shares ("Placing Shares") at a price of 2.5...
RNS 9485280 ↗
20 Mar 26

MedPal Enters At-Home Blood Testing Market

MedPal AI (AIM: MPAL, FRA: Z1N), the UK digital health and AI company, today announces its entry into the at-home blood testing market with the launch of the MedPal weight loss blood test.
RNS 9484180 ↗
16 Mar 26

Pharmacy Operational Update

MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to provide an operational update on pharmacy dispensing volumes at its wholly-owned subsidiary, MedPal Limited.
RNS 9475925 ↗
09 Mar 26

Notice of AGM and Board Changes
RNS 9464392 ↗
27 Feb 26

Final Results

Final Results for the year ended 31 August 2025
RNS 9451802 ↗
27 Feb 26

Total Voting Rights
RNS 9450939 ↗
25 Feb 26

Update and close of ATM

The Company has raised further gross proceeds of approximately £303,355.50 via the ATM facility through the issue of 6,055,000 new ordinary shares ("ATM Shares") at an average price of approximately 5.01p per ATM Share.
RNS 9447343 ↗
16 Feb 26

Completion of Acquisition

Completion of Acquisition of Universal Pharmacy assets and Expansion of Robotic Distribution Facility in Swaffham
RNS 9431342 ↗
12 Feb 26

Result of ATM - replacement

This announcement replaces announcement no.6641S 'Update on ATM Facility' released on 11 February 2026.
RNS 9428112 ↗
11 Feb 26

Update on ATM Facility

The Company has raised further gross proceeds of approximately £467,640 via the ATM facility through the issue of 9,000,000 new ordinary shares ("ATM Shares") at an average price of approximately 5.20p per ATM Share.
RNS 9426584 ↗
10 Feb 26

Vertically Integrated Healthcare Model

Operational Update: Vertically Integrated UK Healthcare Platform and Multi-Channel Revenue Model
RNS 9422500 ↗
05 Feb 26

Pharmacy operations update

MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to announce the continued strong performance of automated pharmacy operations at its wholly-owned subsidiary, MedPal Limited.
RNS 9410005 ↗
03 Feb 26

Secondary Listing on Frankfurt Exchange

MedPal AI (AIM: MPAL, FRA: Z1N), a UK-based digital health and artificial intelligence ("AI") company focused on health and wellness management, is pleased to announce that the Company's ordinary shares have been admitted to trading on the Open Market...
RNS 9405561 ↗
30 Jan 26

Total Voting Rights
RNS 9396095 ↗
28 Jan 26

Eli Lilly Supply Agreement

MedPal AI plc (AIM: MPAL), the AI-powered digital health company, is pleased to announce that MedPal Limited, its wholly owned subsidiary, has been approved as an authorised purchaser of Eli Lilly pharmaceutical products in the United Kingdom.
RNS 9390314 ↗
26 Jan 26

Result of ATM

The Company has raised further gross proceeds of approximately £339,560 via the ATM facility through the issue of 6,500,000 new ordinary shares ("ATM Shares") at an average price of approximately 5.22p per ATM Share.
RNS 9387662 ↗
22 Jan 26

Operational Efficiency Gains in Pharmacy

MedPal AI plc (AIM: MPAL), the digital health and AI company, is pleased to announce that, following recent technology infrastructure upgrades, it has achieved a substantial improvement in dispensing efficiency within its wholly owned subsidiary MedPal Limited.
RNS 9374531 ↗
16 Jan 26

Update on ATM Facility

MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company focused on health and wellness management, is pleased to provide an update on its At-The-Market ("ATM") equity issuance facility that it announced on 4 December 2025.
RNS 9359304 ↗
08 Jan 26

AI Integration with MedPal Clinic

MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company, is pleased to announce the launch of what the Directors believe to be a UK-first: direct AI integration between a consumer health app and a regulated pharmacy,...
RNS 9340089 ↗
05 Jan 26

Trading Update

FDA Approves First Oral GLP-1 for Weight Loss
RNS 9333694 ↗
16 Dec 25

Update on ATM Facility

The Company has raised gross proceeds of approximately £498,225 via the ATM facility through the issue of 7,500,000 new ordinary shares ("ATM Shares") at an average price of 6.643p per ATM Share.
RNS 9298640 ↗
09 Dec 25

CEO Interview on Vox Markets

MedPal AI plc (AIM: MPAL), the UK-based digital health and artificial intelligence company, is pleased to announce the publication of a feature interview with Chief Executive Officer Jason Drummond on Vox Markets, one of the UK's leading platforms for...
RNS 9284549 ↗
08 Dec 25

App Update and Rollout to Epassi UK Gym Network

Major App Update and Rollout to Epassi UK Gym Network
RNS 9281049 ↗
04 Dec 25

Trading Update and At The Market Facility

MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company focused on health and wellness management, is pleased to provide a trading update on its pharmacy operations for November 2025 and also announce that its wholly...
RNS 9274561 ↗
10 Nov 25

NHS Approval & Operational Update

MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company focused on health and wellness management, is pleased to announce that its wholly owned subsidiary, MedPal Limited, has received formal approval from Norfolk and...
RNS 9222211 ↗
07 Nov 25

Launch of MedPal Clinic Pharmacy Platform

Launch of MedPal.clinic: UK's First AI-Powered, Multimodal Pharmacy Platform
RNS 9218389 ↗
03 Nov 25

Initiation of research

MedPal AI plc (AIM:MPAL), a UK-based digital health and artificial intelligence (AI) company is pleased to announce the initiation of research by Optimo Capital Limited's research arm, Optimo Research Ltd ("Optimo Research").
RNS 9207527 ↗
22 Oct 25

Opening of AI-powered National Distribution Centre

Further to its announcement on 1 October 2025 regarding the acquisition of key assets from Universal Pharmacy Limited (in administration) ("Universal"), Medpal (AIM:MPAL), is pleased to announce the opening of a distribution centre at Ecotech Business...
RNS 9185838 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.